EQUITY (Details) - Warrant [Member] |
3 Months Ended |
---|---|
Mar. 31, 2024
$ / shares
shares
| |
Number Of Shares Outstanding, Beginning | shares | 242,633 |
Number Of Shares Outstanding, Expired | shares | (3,276) |
Number Of Shares Outstanding, Ending | shares | 239,357 |
Weighted Average Exercie Price, Beginning | $ 44.07 |
Weighted Average Exercise Price, Granted | 0 |
Weighted Average Exercise Price Expired | 210.00 |
Weighted Average Exercise Price Exercised | 0 |
Weighted Average Exercie Price, Ending | $ 46.82 |
Weighted Average Life (years), Beginning | 1 month 3 days |
Weighted Average Life (years), Ending | 11 months 26 days |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|